Wisniewski DJ, Voeller D, Addissie YA, Deshmukh SK, Wu S, Lustberg MB, Wangsa D, Wangsa D, Heselmeyer-Haddad K, Greer YE, Sledge GW, Lipkowitz S. EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition. Oncogene. 2026 Jan;45(1):15-25. doi: 10.1038/s41388-025-03634-3. Epub 2025 Nov 25. PMID: 41291067; PMCID: PMC12714574.
View All Publications
